Professional Documents
Culture Documents
lecture II-2
Irritable Bowel Syndrome
Malabsorbtion Syndrom
Inflammation Bowel Disease
Stomach
Calcium
Magnesium
Iron
Monosaccharides
Bile
Pancreatic enzymes
Oil-soluble vitamins
Small intestine
Water-soluble
vitamins
Fatty acids
Bile acids
Vitamin B12
Electrolytes
Amino acids
Large
intestine
Wather
Motility
- Serotonin
- Acetylcholine
- Nitric oxide
- Substance C
- Vasoactive intestinal peptide
- Cholecystokinin
Syndromes
Syndrome of intestinal
dyspepsia
Maldigestion
syndrome
Malabsorbtion
syndrome
Bleeding from lower
part of GI tract
Acute abdomen
Irritable bowl
syndrome
Diseases
Celiacia
Whipples disease
Lactase insufficiency
Inflammatory bowl
diseases:
Crones disease
Ulcerative colitis
Diarrhea
1. Transit of soft stools with a lot of fluid
2. > 3 times per day
3. Imperative demand of defecation
Diarrhea
small intestine
large intestine
Diagnosis of diarrhea
If chronic full investigation in every case
Acute investigation is indicated if there are signs of anxiety or
special anamnesis' data
Plan of investigation depend on anamnesis data
Signs of anxiety
Symptoms >48 hours
Severe pain
Body temperature >38,9
Blood or helminthes in stool
Signs of dehydration (dry mouth, thirst, reduction of skin turgor,
oligo- or anuria, vertigo)
Malabsorbtion syndrome
ischemia
Gastrogenic peptic ulcer, gastritis, cancer
Pancreatogenic pancreatitis, mucoviscidosis, tumors
Hepatogenic acute and chronic liver diseases
Postresection state
Endocrinogenic DM, disthyreosis
Drugs
Radiation
Pathogenic factors
enzimopathy
damage of specific transport mechanisms
immunologic disorders
small intestine bacterial overgrowth
motility abnormalities
morphologic changes of mucose
Diagnosis of malabsorption
Blood tests detection of nutrients deficiency
albumin, cholesterol, iron, calcium, magnesium, vitamin A, folic acid
Stool tests
steatorrhea, creatorrhea, amylorrhea, <6,0
big fecal mass (>500 g/day),
amount of fat in stool >6 g/day
Assessment of absorption function with specific tests
absorption test with D-xilose
Schilling test
Instrumental methods
X-ray investigation of small intestine
abdominal ultrasound
endoscopy of small intestine with biopsy
enzymes
Celiac disease
biopsy of small intestine
normal
pathology
Whipples disease
First described in 1907
Etiology: Tropheryma Whipplei [trophi (nutrition) eryma (barier)], first successful
culture was received in 2000.
Prevalence: a rare disease, male:female8:1, mean age 50
Clinical manifestations: malabsorption syndrome, diarrhea, weight loss, fever, arthritis
and arthralgias, cardiac involvment
Diagnosis: biopsy of small intestine. Specific sign infiltration of mucosa with big
macrophages with SHIK-positive granules. In the cells - T. Whipplei.
Treatment: antibiotics
Whipples disease
Irritable Bowel
Syndrome
Brain stem
Spinal
cord
Viscera
+
Any 2 or more of down listed criteria:
Relief after defecation; and/or
Start is associated with changed frequency of stool; and/or
Start is associated with changed consistency of stool
* Presence of named criteria during last 3 months, if first
manifestation appeared 6 months before diagnosis
Diarrhea &
pain
Diarrhea,
constipation &
pain
Constipation
&
pain
Red Flags
Additional diagnostic screening needed
for atypical presentations such as:
Anemia
Fever
Persistent diarrhea
Rectal bleeding
Severe constipation
Weight loss
Nocturnal symptoms of
pain
and abnormal bowel
function
Family history of GI
cancer, inflammatory
bowel disease,
or celiac disease
New onset of symptoms in
patients 50+ years of age
Differential Diagnosis
Management of IBS
Positive diagnosis of the syndrome, exclusion of organic disorders
Life style modification
fibers consumption, change of nutrition character, assessment of patients
psychological status
Symptomatic therapy
Antagonists/agonists of
serotoninergic receptors
Alternative therapy
Anti-diarrheals
Alosetron (Lotronecs)
(in case of diarrhea)
Hypnotherapy
Laxatives
Tegaserod (Zelnorm)
(in case of constipation)
Holistic therapy
Antispasmodics
Aciolitics
Antidepressants
Correction cognitive
changes
Crohns disease
Crohns disease
Pathogenesis
Nonspecific ulcerative colitis
Etiology is unknown
Genetic and immunological factors lead to abnormalities in
recognizing auto antigens in GIT
Crohns disease
Ulcerative colitis
Localization of
damage
Volume of
damage
Depth of damage
Ulcerative colitis
Chronic diffuse inflammation of large intestine with edema and
superficial ulceration of mucosa
Starts always from damage of rectum, and than the process involves
other parts of large intestine
Symptoms:
Complications:
Toxic megacolon (dilation of the gut with
thinning of gut wall, high risk of perforation)
Large intestine carcinoma (constant
regeneration of epithelium---> displasia).
Crohns disease
Chronic granulematose (in some cases transmural) inflammation of the gut wall
of unknown origin
Damage may be localized in any part of GIT from oral cavity up to anus,
damaged areas, crypt abscesses
45%: terminal ilea involvement and larg intestine
33%: small intestine
25%: large intestine
UC
Abdominal pain
+++
Trasmural damage
++
Granulomas
++
Cobblestoning mucosa
++
Asymmetria
+++
Involvement of ilea
+++
Rectal damage
20%
100%
Rectal bleeding
50%
++
Strictures, fistulas
+++
Crypt abscesses
+++
Treatment of IBD
Increase of agression
Experimental treatment
(IL 10, azathioprin iv)
Inhibitor of tumor necrosis
factor (TNF )
Cytostatics
Corticosteroids
Antibiotics
Sulfonamides, salysilates